ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,67%
Bitcoin
66 745,51
2,31%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. GT Biopharma Inc (GTBP)

  7. GT Biopharma Inc (GTBP) Actualités

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GTBP
DateHeureSourceTitreSymboleSociété
15/05/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
14/02/202420h46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
01/02/202418h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
06/11/202323h25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
06/11/202323h21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
27/10/202323h23Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
19/09/202317h56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
16/08/202301h29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
05/05/202323h30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GTBPGT Biopharma Inc
05/05/202323h29Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:GTBPGT Biopharma Inc
05/05/202301h15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GTBPGT Biopharma Inc
04/05/202315h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTBPGT Biopharma Inc
12/04/202301h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTBPGT Biopharma Inc
30/03/202323h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GTBPGT Biopharma Inc
14/02/202318h55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GTBPGT Biopharma Inc
04/01/202312h02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GTBPGT Biopharma Inc
21/10/202212h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GTBPGT Biopharma Inc
13/09/202212h20TipRanksAnalysts Offer Insights on Healthcare Companies: Dynavax (DVAX), Ascendis Pharma (ASND) and GT Biopharma (GTBP)NASDAQ:GTBPGT Biopharma Inc
17/08/202223h01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GTBPGT Biopharma Inc
15/08/202215h38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GTBPGT Biopharma Inc
25/07/202222h36Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GTBPGT Biopharma Inc
19/05/202217h45TipRanksB.Riley Financial Thinks GT Biopharma’s Stock is Going to RecoverNASDAQ:GTBPGT Biopharma Inc
29/04/202223h21Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GTBPGT Biopharma Inc
19/04/202223h31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GTBPGT Biopharma Inc
12/04/202212h26TipRanksGT Biopharma (GTBP) Receives a Buy from H.C. WainwrightNASDAQ:GTBPGT Biopharma Inc
11/03/202212h28TipRanksH.C. Wainwright Sticks to Its Buy Rating for GT Biopharma (GTBP)NASDAQ:GTBPGT Biopharma Inc
03/03/202212h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GTBPGT Biopharma Inc
29/12/202123h26Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:GTBPGT Biopharma Inc
23/08/202113h00PR Newswire (US)GT Biopharma Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical OfficerNASDAQ:GTBPGT Biopharma Inc
13/08/202113h30PR Newswire (US)GT Biopharma Provides Second Quarter 2021 Business UpdateNASDAQ:GTBPGT Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:GTBP

Dernières Valeurs Consultées

COIN
XEPETH
BIT
UC4NJY
Unicredit Bank
BOV
LUXM3
TREVISA ON
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés